| Income Statement |
| Operating Expenses | 6.95M |
|
| Research and Development Expense | 3.53M |
| Selling, General and Administrative Expense | 3.42M |
| Operating Income | -6.95M |
| Net Income | -6.37M |
| Net Income Common Stock | -6.37M |
| Net Income Common Stock (USD) | -6.37M |
| Consolidated Income | -6.37M |
| Earnings per Basic Share | -0.14 |
| Earnings per Basic Share (USD) | -0.14 |
| Earnings per Diluted Share | -0.14 |
| Earning Before Interest & Taxes (EBIT) | -6.37M |
| Earning Before Interest & Taxes (USD) | -6.37M |
| Weighted Average Shares | 45.21M |
| Weighted Average Shares Diluted | 45.21M |
| Balance Sheet |
| Cash and Equivalents | 34.41M |
| Cash and Equivalents (USD) | 34.41M |
| Current Assets | 35.32M |
| Total Assets | 35.32M |
| Current Liabilities | 6.32M |
| Total Liabilities | 7.56M |
| Accumulated Retained Earnings (Deficit) | -116.00M |
| Accumulated Other Comprehensive Income | -39.67K |
| Shareholders Equity | 27.76M |
| Shareholders Equity (USD) | 27.76M |
| Assets Non-Current | 7.52K |
| Liabilities Non-Current | 1.24M |
| Trade and Non-Trade Payables | 2.98M |
| Cash Flow |
| Net Cash Flow from Financing | 31.05M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 25.76M |
| Issuance (Purchase) of Equity Shares | 33.05M |
| Net Cash Flow from Operations | -5.31M |
| Effect of Exchange Rate Changes on Cash | 14.09K |
| Share Based Compensation | 650.02K |